Analysts have been eager to weigh in on the Technology sector with new ratings on OptimizeRx (OPRX – Research Report) and UiPath (PATH – Research Report). OptimizeRx (OPRX) RBC Capital analyst Sean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback